文献速递心血管PETCT

靶向蛋白水解IV型胶原的放射性示踪剂对弥漫性心脏纤维化的分子成像

Molecular Imaging of Diffuse Cardiac Fibrosis with a Radiotracer That Targets Proteolyzed Collagen IV.
PubMed 文献 · Radiol Cardiothorac Imaging · 2024-01-01

研究开发了靶向蛋白水解IV型胶原的肽类示踪剂64Cu-T-peptide-MeCOSar,在过度表达β2肾上腺素能受体的转基因小鼠中行PET/CT,发现纤维化心脏示踪剂结合较健康对照显著升高2.24-4.26倍(P < .05),并可检出中度纤维化的年轻转基因小鼠,竞争实验证实结合特异性。

要点

  • 靶向蛋白水解IV型胶原的肽类PET示踪剂可在体检测弥漫性心脏纤维化。
  • 纤维化心脏示踪剂结合较健康对照升高2.24-4.26倍(P < .05),贯穿45分钟采集期。
  • 中度纤维化年轻转基因小鼠仅在注射后20分钟起可见结合升高1.6-2.2倍(P < .05)。

核心结论

  • 靶向蛋白水解IV型胶原的T-peptide PET示踪剂在转基因小鼠模型中提供了灵敏且特异地检测不同程度弥漫性心脏纤维化的方法。

研究设计与样本

  • 动物实验研究,使用过度表达β2肾上腺素能受体的雄性转基因小鼠,中度纤维化组(7月龄,每组n = 4)与重度纤维化组(10月龄,每组n = 11)及野生型对照,静脉注射64Cu-T-peptide-MeCOSar(0.25 mg/kg;18 MBq ± 2.7 [SD])后行PET/CT,并以过量非标记T-peptide共给药验证结合特异性。

诊断标准与关键数值

  • 纤维化心脏较健康对照64Cu-T-peptide-MeCOSar结合升高2.24-4.26倍(P < .05);中度纤维化年轻转基因小鼠注射后20分钟起结合升高1.6-2.2倍(P < .05);静态扫描用t检验,动态扫描用方差分析(单因素或双因素)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To develop an approach for in vivo detection of interstitial cardiac fibrosis using PET with a peptide tracer targeting proteolyzed collagen IV (T-peptide). Materials and Methods T-peptide was conjugated to the copper chelator MeCOSar (chemical name, 5-(8-methyl-3,6,10,13,16,19-hexaaza-bicyclo[6.6.6]icosan-1-ylamino)-5-oxopentanoic acid) and radiolabeled with copper 64 (64Cu). PET/CT scans were acquired following intravenous delivery of 64Cu-T-peptide-MeCOSar (0.25 mg/kg; 18 MBq ± 2.7 [SD]) to male transgenic mice overexpressing β2-adrenergic receptors with intermediate (7 months of age; n = 4 per group) to severe (10 months of age; n = 11 per group) cardiac fibrosis and their wild-type controls. PET scans were also performed following coadministration of the radiolabeled probe with nonlabeled T-peptide in excess to confirm binding specificity. PET data were analyzed by t tests for static scans and analysis of variance tests (one- or two-way) for dynamic scans. Results PET/CT scans revealed significantly elevated (2.24-4.26-fold; P < .05) 64Cu-T-peptide-MeCOSar binding in the fibrotic hearts of aged transgenic β2-adrenergic receptor mice across the entire 45-minute acquisition period compared with healthy controls. The cardiac tracer accumulation and presence of diffuse cardiac fibrosis in older animals were confirmed by gamma counting (P < .05) and histologic evaluation, respectively. Coadministration of a nonradiolabeled probe in excess abolished the elevated radiotracer binding in the aged transgenic hearts. Importantly, PET tracer accumulation was also detected in younger (7 months of age) transgenic mice with intermediate cardiac fibrosis, although this was only apparent from 20 minutes following injection (1.6-2.2-fold binding increase; P < .05). Conclusion The T-peptide PET tracer targeting proteolyzed collagen IV provided a sensitive and specific approach of detecting diffuse cardiac fibrosis at varying degrees of severity in a transgenic mouse model. Keywords: Diffuse Cardiac Fibrosis, Molecular Peptide Probe, Molecular Imaging, PET/CT © RSNA, 2024.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Niego B, Jupp B, Zia NA, et al. Molecular Imaging of Diffuse Cardiac Fibrosis with a Radiotracer That Targets Proteolyzed Collagen IV. Radiol Cardiothorac Imaging. 2024. PMID: 38512024. doi:10.1148/ryct.230098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。